DHR vs NOW: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and ServiceNow, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-18.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
ServiceNow, Inc. · Technology
$103.24
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
NOW has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
NOW |
| Current Price |
$195.98 |
$103.24 |
| Fair Value Estimate |
$211.54 |
$149.70 |
| Upside to Fair Value |
+7.9%
|
+45.0%
|
| Market Cap |
$138.7B |
$106.5B |
| Forward P/E |
37.8x
|
61.1x
|
| EV / EBITDA |
22.8x
|
32.9x
|
| Price / Sales |
5.6x
|
7.6x
|
| Price / FCF |
26.2x
|
23.0x
|
| Revenue Growth YoY |
+3.7%
|
+22.1%
|
| Gross Margin |
60.7%
|
76.6%
|
| Operating Margin |
21.0%
|
13.4%
|
| Return on Equity |
7.1%
|
15.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
4.35%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
ServiceNow, Inc. operates in the technology sector specializing in software applications, delivering high-quality enterprise cloud solutions with a durable competitive moat evidenced by a 15% return on equity and strong gross margins of 76.6%. The company is currently in an investing growth phase with 22.1% revenue growth in the most recent quarter, although earnings growth is modest at 2.0%. Des…
Accumulation Zones
| Metric |
DHR |
NOW |
| Zone Low |
$158.66 |
$112.27 |
| Zone High |
$179.81 |
$127.24 |
| In Buy Zone? |
No
|
Yes
|